What is it used for?
Jeselhy contains pimitespib, an HSP90 inhibitor. Taiho’s Japanese approval announcement describes gastrointestinal stromal tumors that have progressed following cancer chemotherapy. A current Japanese label and the previous treatment record are needed for an individual review.Jeselhy contains pimitespib, an HSP90 inhibitor. Taiho’s Japanese approval announcement describes gastrointestinal stromal tumors that have progressed following cancer chemotherapy. A current Japanese label and the previous treatment record are needed for an individual review.
Read the primary sourceThis source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.
Product details
- Active ingredient
- pimitespibpimitespib
- Form and strength
- Oral tablets containing 40 mg pimitespib.Oral tablets containing 40 mg pimitespib.
- Manufacturer / applicant
- Taiho Pharmaceutical Co., Ltd.Taiho Pharmaceutical Co., Ltd.
Oral tablets containing 40 mg pimitespib.Oral tablets containing 40 mg pimitespib.
Safety and clinical review
This approval announcement is not the full safety label. Ask the clinical team to review the current Japanese prescribing information before deciding whether this medicine is appropriate.This approval announcement is not the full safety label. Ask the clinical team to review the current Japanese prescribing information before deciding whether this medicine is appropriate.
- Current Japanese prescribing informationCurrent Japanese prescribing information
- Previous GIST medicinesPrevious GIST medicines
- Adverse effects and monitoringAdverse effects and monitoring
Ask your clinician to review the complete label, medical history, other medicines, allergies, pregnancy or breastfeeding and any required monitoring. Do not start, stop or change treatment from this page.
Read the primary sourcePrepare your enquiry
Include the brand or generic name, strength, dosage form, requested quantity and country where care is needed. You can attach a prescription when you continue.
Questions patients ask
What is Jeselhy used for?
Jeselhy contains pimitespib, an HSP90 inhibitor. Taiho’s Japanese approval announcement describes gastrointestinal stromal tumors that have progressed following cancer chemotherapy. A current Japanese label and the previous treatment record are needed for an individual review.Jeselhy contains pimitespib, an HSP90 inhibitor. Taiho’s Japanese approval announcement describes gastrointestinal stromal tumors that have progressed following cancer chemotherapy. A current Japanese label and the previous treatment record are needed for an individual review.
This source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.
Which formulation of Jeselhy should I ask about?
Oral tablets containing 40 mg pimitespib.Oral tablets containing 40 mg pimitespib.
Read the primary sourceWhat determines the price of Jeselhy?
A current quote depends on the exact presentation, quantity, provider and access arrangements. A catalogue entry is not a stock or delivery promise. Medical charges are paid to the provider, separately from coordination fees.
What should I check before using Jeselhy?
Ask your clinician to review the complete label, medical history, other medicines, allergies, pregnancy or breastfeeding and any required monitoring. Do not start, stop or change treatment from this page.
Sources and review scope
This source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.